Better Buy: Abbott Laboratories vs. Pfizer

Investors looking for large-cap, dividend-paying healthcare stocks have plenty of options. Whether it's large-scale drug manufacturers or medical technology providers, there's enough choice to suit whatever you're looking for.

Abbott Laboratories (NYSE: ABT) and Pfizer (NYSE: PFE) both have large market valuations, solid dividends, and a strong track record of success. However, they operate in different areas of the healthcare market, with Abbott developing diagnostic equipment while Pfizer focuses on developing new pharmaceutical candidates.

If you had to choose between the two, however, which is the better investment?

Continue reading

Source Fool.com